Immunogenicity and Safety of 2 Schedules of ALVAC-HIV vCP1452 in Chronically HIV-Infected Patients
Clinical trial NCT00219362 · COMPLETED
Trial details
- NCT number
- NCT00219362
- Sponsor
- Objectif Recherche Vaccins SIDA
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-04-01
- Primary completion
- 2005-11-01
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.